Director, NIH Countermeasures Against Chemical Threats (CounterACT) Program
National Institute of Neurological Disorders and Stroke (NINDS), NIH
Dr. David A. Jett is Director of the NIH Countermeasures Against Chemical Threats (CounterACT) Program, a program supported by a specific Congressional appropriation to the NIH for the development of new drugs and diagnostic tools for treating victims of chemical exposures during an emergency. He also serves as Program Director within the Division of Translational Research at the National Institute of Neurological Disorders and Stroke (NINDS). After receiving a Ph.D. in Neuropharmacology and Toxicology at the University of Maryland School of Medicine, Dr. Jett conducted post-doctoral research and subsequently joined the faculty at Johns Hopkins University’s Bloomberg School of Public Health where he conducted research as a university professor for several years. Dr. Jett’s scientific interest is in the impact of chemical agents on nervous system function, including the molecular and cellular mechanisms of cognitive and neural development. Specifically, he has expertise and experience with pesticides and nerve agents.
Dr. Jett is has authored many scientific articles and book chapters in the area of neurotoxicology and has chaired sessions and given keynote addresses at many national and international scientific meetings. He holds the position of Adjunct Professor of Epidemiology and Public Health, University of Maryland School of Medicine. Dr. Jett has served on White House and intergovernmental committees that set the nation’s research priorities, as well as science advisory panels for the Environmental Protection Agency and the Department of Defense. Dr. Jett’s other major interest at NIH is training and programs designed to increase diversity in the neuroscience research workforce.